False-positive Newborn Screening Mimicking Glutaric Aciduria Type I ...
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation- Clipboard
- My Bibliography
- Collections
- Citation manager
Save citation to file
Format: Summary (text) PubMed PMID Abstract (text) CSV Create file CancelEmail citation
Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email CancelAdd to Collections
- Create a new collection
- Add to an existing collection
Add to My Bibliography
- My Bibliography
Your saved search
Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons- Yes
- No
Create a file for external citation management software
Create file CancelYour RSS Feed
Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link CopyFull text links
Wiley Full text links Actions
CiteCollectionsAdd to Collections- Create a new collection
- Add to an existing collection
Page navigation
- Title & authors
- Abstract
- References
- MeSH terms
- Substances
- Supplementary concepts
- LinkOut - more resources
Abstract
Glutaric aciduria type I (GA I), an autosomal-recessive deficiency of glutaryl-CoA-dehydrogenase, leads to encephalopathic crises resulting in irreversible neurological damage. As early diagnosis and implementation of appropriate treatment has significant benefit for these patients, GA I has been implemented in the extended newborn screening program in several countries. Screening parameter is glutarylcarnitine (C5DC) with its ratios. From 1 January 2005 until 31 December 2008, 173,846 newborns were examined by neonatal screening in our screening center. C5DC and/or at least three C5DC/acylcarnitine ratios were increased in 53 newborns (0.03%) and persisted in 11 infants after recall. GA I was not confirmed in any of these infants, but all 11 infants were suffering from renal insufficiency due to congenital (5/11) or acquired (6/11) renal disease. C5DC was shown to be significantly associated with renal affection and was significantly higher in infants with congenital renal insufficiency than in those with acquired renal insufficiency (p = 0.011). Creatinine correlated significantly with C5DC (p = 0.001) and all C5DC/acylcarnitine ratios, mainly with C5DC/(C8 + C10), C5DC/C0, C5DC/C2, C5DC/C4, and C5DC/C8 (for all: p = 0.001). Glutarylcarnitinemia associated with renal insufficiency has not yet been studied systematically. Renal damage in neonates might lead to disturbances in renal transporter systems of glutaric acid and its metabolites and a decreased excretion of C5DC, thus resulting in an increase of plasma C5DC. Therefore, newborns presenting with a positive screening indicating GA I may be considered not only to suffer from GA I but from renal insufficiency as well.
PubMed Disclaimer
References
-
- Pediatr Res. 2007 Sep;62(3):357-63 - PubMed
-
- Clin Chem. 2001 Nov;47(11):1945-55 - PubMed
-
- J Inherit Metab Dis. 2008 Apr;31(2):188-93 - PubMed
-
- Pediatrics. 2001 May;107(5):1184-7 - PubMed
-
- Cancer Biol Ther. 2005 Aug;4(8):815-8 - PubMed
MeSH terms
- Amino Acid Metabolism, Inborn Errors / blood Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Amino Acid Metabolism, Inborn Errors / diagnosis* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Brain Diseases, Metabolic / blood Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Brain Diseases, Metabolic / diagnosis* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carnitine / analogs & derivatives Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carnitine / blood Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Diagnosis, Differential Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- False Positive Reactions Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Female Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Germany Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Glutaryl-CoA Dehydrogenase / blood Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Glutaryl-CoA Dehydrogenase / deficiency Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Humans Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Infant, Newborn Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Male Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Neonatal Screening* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Renal Insufficiency / blood Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Renal Insufficiency / congenital Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Renal Insufficiency / diagnosis* Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Substances
- glutarylcarnitine Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Glutaryl-CoA Dehydrogenase Actions
- Search in PubMed
- Search in MeSH
- Add to Search
- Carnitine Actions
- Search in PubMed
- Search in MeSH
- Add to Search
Supplementary concepts
- Glutaric Acidemia I Actions
- Search in PubMed
- Search in MeSH
- Add to Search
LinkOut - more resources
Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal
Wiley [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To - Clipboard
- Save
- My Bibliography
- Collections
- Citation Manager
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Từ khóa » C5dc High
-
C5DCU - Overview: C5-DC Acylcarnitine, Quantitative, Random, Urine
-
[PDF] Elevated C5-DC Acylcarnitine Family Fact Sheet
-
Renal Insufficiency Mimicking Glutaric Acidemia Type 1 On Newborn ...
-
Detection Of Glutaric Acidemia Type 1 In Infants Through Tandem Mass ...
-
[PDF] When Baby Needs A Second Test For An Organic Acid Disorder
-
[PDF] Suggested Follow-up For Elevated C5DC+C6OH: Glutaryl Carnitine
-
Biochemical And Molecular Features Of Chinese Patients With Glutaric ...
-
[PDF] Newborn Screening ACT Sheet Elevated C5-DC Acylcarnitine ...
-
Prenatal Diagnosis Of Glutaric Acidemia I Based On Amniotic Fluid ...
-
Diagnosis Of Glutaric Acidemia Type I: A Cautionary Note
-
[PDF] Glutaric Aciduria Type I Missed By Newborn Screening - MDPI
-
Glutaric Aciduria Type I - National Organization For Rare Disorders
-
The Low Excretor Phenotype Of Glutaric Acidemia Type I Is A Source Of ...